Chemistry, Manufacturing, and Controls (CMC) Scientific Support

Chemistry, Manufacturing, and Controls (CMC) scientific support covers how the product is made, tested, and controlled from development through commercialization. Regulators expect a coherent story on process understanding, specifications, analytical methods, stability, and how changes are managed. CMC gaps delay INDs, create clinical supply risk, and turn late-stage filings into remediation projects when Module 3 cannot explain how quality is assured lot after lot.

Viltis provides CMC scientific consulting for small molecules, biologics, and related modalities: control strategy input, analytical method lifecycle thinking, impurity and comparability questions, and Module 3 authorship support. We work with process development, analytical, quality, and regulatory so the science in the filing matches what manufacturing can actually run. When a CMO holds the process, we help sponsors stay technically fluent enough to oversee without owning every flask, and we flag process or specification choices that will not survive scale or inspection.

Comparability after process or site changes is where CMC science and regulatory strategy meet. We help define what analytical and process evidence is needed to argue sameness, and what would force a deeper bridging package. That planning belongs before the change is locked, not after the first commercial-intent lots are already on the calendar. Stability program design and shelf-life rationale are included when they drive clinical supply or filing timing. Spec justification is kept visible when limits look arbitrary.

CMC scientific support often includes

• Control strategy and specification rationale
• Analytical method and validation strategy input
• Impurity, potency, and stability interpretation
• Comparability and process change assessment
• Module 3 and related CTD writing support
• CMO technical oversight and gap reviews
• Response support for CMC information requests

Strong CMC science reduces manufacturing surprises and shortens the path from process knowledge to a reviewable dossier. Viltis focuses on evidence and clear rationale: what is controlled, why limits make sense, and what still needs work before the next regulatory gate. When agency questions arrive, we help craft responses that answer the science asked, not a pile of unrelated data. If a filing or tech transfer is blocked on CMC questions, we help separate true scientific gaps from documentation debt that can be closed quickly.